Table 2.
Screening for autoantibodies known to be associated to polymyositis, dermatomyositis, and isolated statin (HMG-CoA reductase inhibitor) causing myalgia.
| Antibodies | Results |
|---|---|
| P-Glycyl-tRNA synthetase-Ab. (IgG) | Negative |
| P-Jo 1-antibody (IgG) | Negative |
| P-Histidine-tRNA-ligase (Jo1)-Ab. (IgG) | Negative |
| P-Isoleucyl-tRNA synth. cytop.-Ab. (IgG) | Negative |
| P-MDA5-antibody (IgG) | Negative |
| P-Mi-2a-antibody (IgG) | Negative |
| P-NXP2-antibody (IgG) | Negative |
| P-Polymyositis (Ku)-A (IgG) | Negative |
| P-Polymyositis (PL-12)-antibody | Negative |
| P-Polymyositis (PL-7)-Ab. (IgG) | Negative |
| P-Polymyositis (SRP)-Ab. (IgG) | Negative |
| P-SAE1-antibody (IgG) | Negative |
| P-TIF1 y-antibody (IgG) | Negative |
| HMG-CoA reductase-Ab. (IgG) (HMGCR), normal reference < 20 | <3 |